Pmos

Advocates Say Women With PMOS Should Get Subsidised Weight-Loss Drugs

The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia is pushing for GLP-1 medications to be listed on the Pharmaceutical Benefits Scheme.